 |
Top 8 Glaucoma treatment startups
Updated: April 19, 2024 |
Glaucoma treatment startups are at the forefront of developing innovative technologies such as minimally invasive glaucoma surgery (MIGS) devices, implantable microsensors for intraocular pressure monitoring, and AI-driven diagnostic tools for early detection and personalized treatment.
1
Country: USA | Funding: $509M
Annexon Biosciences a biotechnology company, discovers and developing novel therapeutics for neurodegenerative and autoimmune disorders.
Annexon Biosciences a biotechnology company, discovers and developing novel therapeutics for neurodegenerative and autoimmune disorders.
2
Country: USA | Funding: $381M
Maze Therapeutics is a operator of a biotechnology firm intended to focused on translating genetic insights into new medicines.
Maze Therapeutics is a operator of a biotechnology firm intended to focused on translating genetic insights into new medicines.
3
Country: USA | Funding: $173.4M
IDx is a leading AI diagnostics company on a mission to transform the quality, accessibility, and affordability of healthcare. The company’s first product, IDx-DR, is an FDA-cleared AI-based diagnostic system designed for use at the front lines of care to detect diabetic retinopathy. IDx is developing additional AI-based diagnostic algorithms for the detection of macular degeneration, glaucoma, Alzheimer’s disease, cardiovascular disease, and stroke risk.
IDx is a leading AI diagnostics company on a mission to transform the quality, accessibility, and affordability of healthcare. The company’s first product, IDx-DR, is an FDA-cleared AI-based diagnostic system designed for use at the front lines of care to detect diabetic retinopathy. IDx is developing additional AI-based diagnostic algorithms for the detection of macular degeneration, glaucoma, Alzheimer’s disease, cardiovascular disease, and stroke risk.
4
Country: Switzerland | Funding: $33.4M
Sensimed AG, a Swiss company, has developed a unique non-invasive soft contact lens-based solution, the SENSIMED Triggerfish, with the aim of revolutionizing glaucoma management by providing an automated recording of continuous ocular dimensional change over 24 hours.
Sensimed AG, a Swiss company, has developed a unique non-invasive soft contact lens-based solution, the SENSIMED Triggerfish, with the aim of revolutionizing glaucoma management by providing an automated recording of continuous ocular dimensional change over 24 hours.
5
Country: Germany | Funding: $8.5M
Our EYEMATE eye pressure measurement system consists of an implantable micro sensor, responsible for pressure sensing. It also consists of an external hand held device, which is transferring energy to the micro sensor telemetrically and which is responsible for data read out and storage. A GSM module can be connected with the hand held device for transfer of measurement data to an internet-based database.
Our EYEMATE eye pressure measurement system consists of an implantable micro sensor, responsible for pressure sensing. It also consists of an external hand held device, which is transferring energy to the micro sensor telemetrically and which is responsible for data read out and storage. A GSM module can be connected with the hand held device for transfer of measurement data to an internet-based database.
6
Country: Israel | Funding: $7.2M
IOPtima develops minimally-invasive surgical ophthalmic devices. The company’s flagship product IOPtimate is a surgical system for the treatment of Glaucoma, which utilizes a CO2 laser technology to significantly reduce internal eye pressure (“IOP”), by restoring the natural fluid percolation without penetrating into the eye.
IOPtima develops minimally-invasive surgical ophthalmic devices. The company’s flagship product IOPtimate is a surgical system for the treatment of Glaucoma, which utilizes a CO2 laser technology to significantly reduce internal eye pressure (“IOP”), by restoring the natural fluid percolation without penetrating into the eye.
7
Country: USA | Funding: $6.1M
Smartlens offers miLens, an electronics-free soft contact lens that allows providers to gather data to monitor diurnal intraocular pressure using microfluidics technology.
Smartlens offers miLens, an electronics-free soft contact lens that allows providers to gather data to monitor diurnal intraocular pressure using microfluidics technology.
8
Country: India | Funding: $40K
Kalpah AI is developing Retinal Image Analysis for Glaucoma. It is an automatic glaucomatous optic disc analysing software which makes use of advanced Machine learning algorithms.
Kalpah AI is developing Retinal Image Analysis for Glaucoma. It is an automatic glaucomatous optic disc analysing software which makes use of advanced Machine learning algorithms.